niacinamide has been researched along with Diabetes Mellitus in 65 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Resveratrol improves insulin sensitivity and lowers hepatic glucose production (HGP) in rat models of obesity and diabetes, but the underlying mechanisms for these antidiabetic effects remain elusive." | 7.81 | Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. ( Baur, JA; Breen, DM; Côté, CD; Daljeet, M; Duca, FA; Filippi, BM; Lam, TK; Rasmussen, BA; Zadeh-Tahmasebi, M, 2015) |
| "To evaluate the effect of sorafenib on the glucose tolerance and diabetic status of patients with metastatic renal cell carcinoma (RCC) or advanced hepatocellular carcinoma (HCC)." | 7.78 | The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma. ( Caccialanza, R; Ganini, C; Imarisio, I; Magnani, L; Paglino, C; Porta, C, 2012) |
| "Resveratrol improves insulin sensitivity and lowers hepatic glucose production (HGP) in rat models of obesity and diabetes, but the underlying mechanisms for these antidiabetic effects remain elusive." | 3.81 | Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. ( Baur, JA; Breen, DM; Côté, CD; Daljeet, M; Duca, FA; Filippi, BM; Lam, TK; Rasmussen, BA; Zadeh-Tahmasebi, M, 2015) |
| "To evaluate the effect of sorafenib on the glucose tolerance and diabetic status of patients with metastatic renal cell carcinoma (RCC) or advanced hepatocellular carcinoma (HCC)." | 3.78 | The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma. ( Caccialanza, R; Ganini, C; Imarisio, I; Magnani, L; Paglino, C; Porta, C, 2012) |
| "Sorafenib, a multitargeted kinase inhibitor used for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinomas, received FDA approval in 2005." | 3.75 | Localized dyskeratotic plaque with milia associated with sorafenib. ( Burkemper, NM; Chappell, JA; Semchyshyn, N, 2009) |
| "The relationship between the dose of intravenously administered streptozotocin (a N-nitroso derivative of glucosamine) and the diabetogenic response has been explored by use of the following indices of diabetogenic action: serum glucose, urine volume, and glycosuria, ketonuria, serum immunoreactive insulin (IRI), and pancreatic IRI content." | 3.65 | Diabetogenic action of streptozotocin: relationship of dose to metabolic response. ( Junod, A; Lambert, AE; Renold, AE; Stauffacher, W, 1969) |
| "The use of topical nicotinamide in the treatment of acne vulgaris; melasma; atopic dermatitis; rosacea; and oral nicotinamide in preventing nonmelanoma skin cancer is discussed." | 2.50 | A review of nicotinamide: treatment of skin diseases and potential side effects. ( Rolfe, HM, 2014) |
| "Diabetes mellitus impacts almost 200 million individuals worldwide and leads to debilitating complications." | 2.49 | Novel directions for diabetes mellitus drug discovery. ( Chong, ZZ; Maiese, K; Shang, YC; Wang, S, 2013) |
| "The attenuation of diabetic kidney disease (DKD) by metabolic surgery is enhanced by pharmacotherapy promoting renal fatty acid oxidation (FAO)." | 1.72 | Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats. ( Abdelaal, M; Abrahamsson, S; Brennan, EP; Chuah, YHD; Docherty, NG; Eckhardt, H; Elliott, JA; Fändriks, L; Fearon, N; Godson, C; Hutter, M; le Roux, CW; Malmodin, D; Martin, WP; Nair, M; Pedersen, A, 2022) |
| "Treatment with pterostilbene resulted in a significant reduction of glycosylated hemoglobin and an increase in total hemoglobin level." | 1.33 | Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats. ( Pari, L; Satheesh, MA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (60.00) | 18.7374 |
| 1990's | 8 (12.31) | 18.2507 |
| 2000's | 5 (7.69) | 29.6817 |
| 2010's | 10 (15.38) | 24.3611 |
| 2020's | 3 (4.62) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, KI | 1 |
| Han, JS | 1 |
| Park, CK | 1 |
| Martin, WP | 1 |
| Nair, M | 1 |
| Chuah, YHD | 1 |
| Malmodin, D | 1 |
| Pedersen, A | 1 |
| Abrahamsson, S | 1 |
| Hutter, M | 1 |
| Abdelaal, M | 1 |
| Elliott, JA | 1 |
| Fearon, N | 1 |
| Eckhardt, H | 1 |
| Godson, C | 1 |
| Brennan, EP | 1 |
| Fändriks, L | 1 |
| le Roux, CW | 1 |
| Docherty, NG | 1 |
| Zhong, Y | 1 |
| Yang, S | 1 |
| Cui, J | 1 |
| Wang, J | 1 |
| Li, L | 1 |
| Chen, Y | 1 |
| Chen, J | 2 |
| Feng, P | 1 |
| Huang, S | 1 |
| Li, H | 1 |
| Han, Y | 1 |
| Tang, G | 1 |
| Hu, K | 1 |
| Rolfe, HM | 1 |
| Côté, CD | 1 |
| Rasmussen, BA | 1 |
| Duca, FA | 1 |
| Zadeh-Tahmasebi, M | 1 |
| Baur, JA | 1 |
| Daljeet, M | 1 |
| Breen, DM | 1 |
| Filippi, BM | 1 |
| Lam, TK | 1 |
| Yilmaz, Z | 1 |
| Piracha, F | 1 |
| Anderson, L | 1 |
| Mazzola, N | 1 |
| Liu, M | 1 |
| Chu, J | 1 |
| Gu, Y | 1 |
| Shi, H | 1 |
| Zhang, R | 1 |
| Wang, L | 1 |
| Shen, L | 1 |
| Yu, P | 1 |
| Chen, X | 1 |
| Ju, W | 1 |
| Wang, Z | 1 |
| Chappell, JA | 1 |
| Burkemper, NM | 1 |
| Semchyshyn, N | 1 |
| Shapiro, S | 1 |
| Rapaport, R | 1 |
| Maiese, K | 2 |
| Shang, YC | 2 |
| Chong, ZZ | 2 |
| Hou, J | 1 |
| WADE, HJ | 1 |
| GORDON, W | 2 |
| NEUWAHL, FJ | 1 |
| Przygodzki, T | 1 |
| Kazmierczak, P | 1 |
| Sikora, J | 1 |
| Watala, C | 1 |
| Agostino, NM | 1 |
| Chinchilli, VM | 1 |
| Lynch, CJ | 1 |
| Koszyk-Szewczyk, A | 1 |
| Gingrich, R | 1 |
| Sivik, J | 1 |
| Drabick, JJ | 1 |
| Gómez Rodríguez, R | 1 |
| Romero Gutiérrez, M | 1 |
| González de Frutos, C | 1 |
| de Artaza Varasa, T | 1 |
| de la Cruz Perez, G | 1 |
| Ciampi Dopazo, JJ | 1 |
| Lanciego Pérez, C | 1 |
| Gómez Moreno, AZ | 1 |
| Imarisio, I | 1 |
| Paglino, C | 1 |
| Ganini, C | 1 |
| Magnani, L | 1 |
| Caccialanza, R | 1 |
| Porta, C | 1 |
| Wang, S | 1 |
| ESER, S | 1 |
| TEKMAN, S | 1 |
| ARAZ, A | 1 |
| OJI, N | 1 |
| PASQUARIELLO, G | 1 |
| LAZAROW, A | 1 |
| LIAMBIES, J | 1 |
| TAUSCH, AJ | 1 |
| Lo, HC | 1 |
| Tsai, FA | 1 |
| Wasser, SP | 1 |
| Yang, JG | 1 |
| Huang, BM | 1 |
| Pari, L | 1 |
| Satheesh, MA | 1 |
| Zhang, J | 1 |
| BANERJEE, S | 1 |
| GHOSH, NC | 1 |
| LeWitt, PA | 1 |
| Unger, RH | 2 |
| Mann, R | 1 |
| Mitchell, EA | 1 |
| Zhu, M | 2 |
| Noma, Y | 1 |
| Mizuno, A | 1 |
| Sano, T | 1 |
| Shima, K | 2 |
| Shimabukuro, M | 1 |
| Ohneda, M | 1 |
| Lee, Y | 1 |
| Novelli, M | 1 |
| Ogino, T | 1 |
| Murakami, T | 1 |
| Kuwajima, M | 1 |
| Mahmoud, AA | 1 |
| Cheever, AW | 1 |
| Warren, KS | 1 |
| Wilander, E | 2 |
| Gunnarsson, R | 1 |
| Slonim, AE | 1 |
| Fletcher, T | 1 |
| Burke, V | 1 |
| Burr, IM | 1 |
| Tjälve, H | 1 |
| Curzon, G | 1 |
| Fernando, JC | 1 |
| Rossini, AA | 1 |
| Like, AA | 1 |
| Chick, WL | 1 |
| Appel, MC | 1 |
| Cahill, GF | 1 |
| Masiello, P | 1 |
| Bergamini, E | 1 |
| Doi, K | 1 |
| Rakieten, N | 2 |
| Gordon, BS | 1 |
| Beaty, A | 1 |
| Cooney, DA | 4 |
| Schein, PS | 6 |
| Dixon, RL | 1 |
| Prosser, PR | 1 |
| Karam, JH | 1 |
| Besedin, SN | 1 |
| Ogura, M | 1 |
| Noda, Y | 1 |
| Suzukui, T | 1 |
| Obrosova, IG | 1 |
| Kirput', SN | 1 |
| Ostrovskiĭ, IuM | 1 |
| Larin, FS | 1 |
| Efimov, AS | 1 |
| Lazarus, SS | 1 |
| Shapiro, SH | 1 |
| Ammon, HP | 2 |
| Bates, RW | 1 |
| Junod, A | 1 |
| Lambert, AE | 1 |
| Stauffacher, W | 2 |
| Renold, AE | 2 |
| Burr, I | 1 |
| Gutzeit, A | 1 |
| Beaven, D | 1 |
| Veleminsky, J | 1 |
| White, JH | 1 |
| Cinotti, AA | 1 |
| Davis, R | 1 |
| Vernon, ML | 2 |
| Tarachand, U | 1 |
| Eapen, J | 1 |
| Akarte, NR | 1 |
| Shastri, NV | 1 |
| Dulin, WE | 2 |
| Wyse, BM | 2 |
| Golden, P | 1 |
| Baird, L | 1 |
| Malaisse, WJ | 1 |
| Malaisse-Lagae, F | 1 |
| Walker, MM | 1 |
| Alberti, KG | 1 |
| Williamson, DH | 1 |
| McMenamin, MG | 1 |
| Anderson, T | 1 |
| Steinke, J | 1 |
5 reviews available for niacinamide and Diabetes Mellitus
| Article | Year |
|---|---|
A review of nicotinamide: treatment of skin diseases and potential side effects.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Chemical and Drug Induced Liver Inju | 2014 |
Supplements for Diabetes Mellitus: A Review of the Literature.
Topics: Animals; Blood Glucose; Cinnamomum zeylanicum; Diabetes Mellitus; Dietary Supplements; Humans; Niaci | 2017 |
The role of complementary and alternative therapies in pediatric diabetes.
Topics: Child; Cinnamomum zeylanicum; Cod Liver Oil; Complementary Therapies; Diabetes Mellitus; Fatty Acids | 2009 |
Novel directions for diabetes mellitus drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Delivery Systems; Drug Discovery; Erythropoietin; Humans; Hypoglyce | 2013 |
Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.
Topics: Acyl Coenzyme A; Adipocytes; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; F | 1995 |
60 other studies available for niacinamide and Diabetes Mellitus
| Article | Year |
|---|---|
Neuroprotective Effects of Nicotinamide (Vitamin B
Topics: Animals; Diabetes Mellitus; Male; Neuroprotective Agents; Niacinamide; Rats; Rats, Sprague-Dawley; R | 2022 |
Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Fenofibrate; Kidney; Male; Niacinamide; PPAR alp | 2022 |
Novel
Topics: Alzheimer Disease; Animals; Bipolar Disorder; Blood-Brain Barrier; Brain; Cell Line, Tumor; Diabetes | 2021 |
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Gene Expression Reg | 2015 |
Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.
Topics: Aged; Biomarkers; Body Mass Index; China; Chromatography, Liquid; Comorbidity; Coronary Angiography; | 2017 |
Localized dyskeratotic plaque with milia associated with sorafenib.
Topics: Acantholysis; Benzenesulfonates; Carcinoma, Hepatocellular; Diabetes Mellitus; Drug Eruptions; Hepat | 2009 |
Diabetes mellitus: channeling care through cellular discovery.
Topics: Animals; Cell Cycle; Cell Survival; Diabetes Mellitus; Erythropoietin; Forkhead Transcription Factor | 2010 |
Nicotinamide and diabetes mellitus.
Topics: Diabetes Mellitus; Niacin; Niacinamide; Nicotinic Acids | 1947 |
Nicotinamide and diabetes mellitus.
Topics: Diabetes Mellitus; Niacin; Niacinamide; Nicotinic Acids | 1947 |
Nicotinamide and diabetes mellitus.
Topics: Diabetes Mellitus; Female; Humans; Labor, Obstetric; Niacin; Niacinamide; Nicotinic Acids; Pregnancy | 1947 |
1-methylnicotinamide effects on the selected markers of endothelial function, inflammation and haemostasis in diabetic rats.
Topics: Animals; Biomarkers; Diabetes Mellitus; Endothelium, Vascular; Hemostasis; Hypolipidemic Agents; Inf | 2010 |
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice.
Topics: Aged; Antineoplastic Agents; Benzamides; Benzenesulfonates; Blood Glucose; Dasatinib; Diabetes Melli | 2011 |
Nicotinic acid amide in diabetes.
Topics: Amides; Diabetes Mellitus; Humans; Niacin; Niacinamide; Nicotinic Acids | 1946 |
[Clinical characteristics, staging and treatment of patients with hepatocellular carcinoma in clinical practice. Prospective study of 136 patients].
Topics: Aged; Alcoholism; Benzenesulfonates; Carcinoma, Hepatocellular; Comorbidity; Diabetes Mellitus; Earl | 2011 |
The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Comorbid | 2012 |
[Effect of nicotinic acid amide on metabolism of alloxan diabetic rat liver in vitro. I. Oxygen consumption in liver cultured in medium containing sodium aceto-acetate and nicotinic acid amide].
Topics: Alloxan; Amides; Diabetes Mellitus; In Vitro Techniques; Liver; Niacin; Niacinamide; Nicotinic Acids | 1957 |
The inactivation of cortisol in experimental diabetic animals.
Topics: Anatomy; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Diabetes M | 1963 |
[RESEARCH ON THE TRYPTOPHAN--NICOTINIC ACID PATHWAY IN DIABETES MELLITUS].
Topics: Diabetes Mellitus; Geriatrics; Hippurates; Insulin; Kynurenic Acid; Kynurenine; Metabolism; Niacin; | 1964 |
Protection against diabetes with nicotinamide.
Topics: Diabetes Mellitus; Humans; Niacin; Niacinamide | 1950 |
Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats.
Topics: Agaricales; Animals; Biomass; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dia | 2006 |
Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dose-Response Relationsh | 2006 |
The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation.
Topics: Acetylation; Amino Acid Substitution; Animals; Cell Line; Cellular Senescence; Diabetes Mellitus; Hu | 2007 |
Effect of nicotinamide on blood sugar and blood acetone bodies of diabetic and normal subjects.
Topics: Blood; Blood Glucose; Diabetes Mellitus; Humans; Ketone Bodies; Niacin; Niacinamide; Nicotinic Acids | 1949 |
The neurotoxicity of the rat poison vacor. A clinical study of 12 cases.
Topics: Adult; Brain Diseases; Diabetes Mellitus; Humans; Hypotension, Orthostatic; Male; Middle Aged; Nervo | 1980 |
Health Research Council and diabetes research.
Topics: Child; Diabetes Mellitus; Double-Blind Method; Humans; Niacinamide; Peer Review; Research | 1993 |
The Health Research Council and diabetes mellitus prevention.
Topics: Child; Clinical Trials as Topic; Diabetes Mellitus; Humans; New Zealand; Niacinamide | 1993 |
Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM.
Topics: Animals; Blood Glucose; Body Weight; Cell Division; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fe | 1996 |
Role of nitric oxide in obesity-induced beta cell disease.
Topics: Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, | 1997 |
Report for the EASD-Bayer Travel Fellowship for Young Scientists 1997. European Association for the Study of Diabetes.
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Europe; Fell | 1998 |
Effect of partial pancreatectomy on beta-cell mass in the remnant pancreas of Wistar fatty rats.
Topics: Animals; Blood Glucose; Cell Division; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, | 1998 |
Streptozotocin-induced diabetes mellitus and the host-parasite relation in murine schistosomiasis mansoni.
Topics: Animals; Blood Glucose; Chronic Disease; Diabetes Mellitus; Granuloma; Humans; Hypersensitivity, Del | 1975 |
Diabetogenic effects of n-nitrosomethylurea in the chinese hamster.
Topics: Animals; Blood Glucose; Cricetinae; Diabetes Mellitus; Female; Islets of Langerhans; Lethal Dose 50; | 1975 |
Effect of streptozotocin on red-blood-cell-reduced glutathione: modification by glucose, nicotinamide, and epinephrine.
Topics: Animals; Diabetes Mellitus; Epinephrine; Glucose; Glutathione; Hexosephosphates; Humans; Male; Niaci | 1976 |
The uptake in the pancreatic islets of nicotinamide, nicotinic acid and tryptophan and their ability to prevent streptozotocin diabetes in mice.
Topics: Animals; Autoradiography; Blood Glucose; Diabetes Mellitus; Islets of Langerhans; Mice; Mice, Inbred | 1976 |
Effect of aminophylline on tryptophan and other aromatic amino acids in plasma, brain and other tissues and on brain 5-hydroxytryptamine metabolism.
Topics: Amino Acids; Aminophylline; Animals; Behavior, Animal; Brain; Diabetes Mellitus; Fatty Acids, Nonest | 1976 |
Studies of streptozotocin-induced insulitis and diabetes.
Topics: Animals; Antilymphocyte Serum; Blood Glucose; Diabetes Mellitus; Dose-Response Relationship, Drug; I | 1977 |
Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection.
Topics: Age Factors; Animals; Diabetes Mellitus; Dose-Response Relationship, Drug; Islets of Langerhans; Nia | 1977 |
[Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Topics: Adenoma, Islet Cell; Amides; Animals; Blood Glucose; Cats; Cystine; Deoxyglucose; Diabetes Mellitus; | 1975 |
Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes.
Topics: Adenocarcinoma; Adenoma; Adenoma, Islet Cell; Animals; Diabetes Mellitus; Dose-Response Relationship | 1976 |
Diabetes mellitus following rodenticide ingestion in man.
Topics: Adult; Diabetes Mellitus; Humans; Insulin; Male; Niacinamide; Pancreas; Peripheral Nervous System Di | 1978 |
[Nicotinic acid balance in diabetes mellitus].
Topics: Adolescent; Adult; Aged; Chronic Disease; Diabetes Mellitus; Female; Humans; Male; Middle Aged; NAD; | 1978 |
[Influence of nicotinamide administration on the bile-acid pattern in rats given streptozotocin].
Topics: Animals; Bile Acids and Salts; Diabetes Mellitus; Drug Therapy, Combination; Insulin; Niacinamide; R | 1990 |
[The action of nicotinamide on the adenine nucleotide system as well as on mitochondrial oxidation and phosphorylation processes in the liver of db/db strain mice].
Topics: Adenine Nucleotides; Animals; Diabetes Mellitus; Diabetes Mellitus, Type 1; Mice; Mice, Inbred C57BL | 1988 |
Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Mice; NAD; | 1973 |
[Stimulation of insulin secretion by tolbutamide. Studies on experimental diabetes].
Topics: Animals; Diabetes Mellitus; Drug Synergism; Glucose; In Vitro Techniques; Insulin; Insulin Secretion | 1973 |
[The use of Stresscaps in diabetics].
Topics: Adult; Aged; Ascorbic Acid; Calcium; Carbohydrate Metabolism; Diabetes Mellitus; Female; Humans; Mal | 1967 |
Plasma glucose levels in normal and adrenalectomized mice treated with streptozotocin and nicotinamide.
Topics: Adrenalectomy; Animals; Antibiotics, Antineoplastic; Blood Glucose; Diabetes Mellitus; Diet; Fasting | 1968 |
Diabetogenic action of streptozotocin: relationship of dose to metabolic response.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Disease Models, Animal; Glucosamine; Glucose Tolerance Te | 1969 |
Streptozotocin diabetes: time course of irreversible B-cell damage; further observations on prevention by nicotinamide.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Injections, Intraperiton | 1970 |
Streptozotocin-produced cataracts in rats.
Topics: Animals; Anti-Bacterial Agents; Blood Glucose; Cataract; Cell Division; Diabetes Mellitus; Glycosuri | 1972 |
Streptozotocin diabetes in monkeys and dogs, and its prevention by nicotinamide.
Topics: Animals; Diabetes Mellitus; Dogs; Haplorhini; Islets of Langerhans; Macaca; Microscopy, Electron; Ni | 1973 |
Effect of streptozotocin-diabetes on in vivo protein synthesis by placenta and liver of mice.
Topics: Animals; Blood Glucose; Body Weight; Carbon Radioisotopes; Diabetes Mellitus; Female; Insulin; Leuci | 1974 |
Studies on tryptophan-niacin metabolism in streptozotocin diabetic rats.
Topics: Animals; Diabetes Mellitus; Diet; Eating; Fluorometry; Male; Niacinamide; Nicotinic Acids; Rats; Str | 1974 |
The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity.
Topics: Animals; Antibiotics, Antineoplastic; Diabetes Mellitus; Drug Antagonism; Islets of Langerhans; Live | 1967 |
Reversal of streptozotocin diabetes with nicotinamide.
Topics: Animals; Antibiotics, Antineoplastic; Blood Glucose; Diabetes Mellitus; Injections, Intraperitoneal; | 1969 |
Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.
Topics: Amino Acids; Animals; Diabetes Mellitus; Diaphragm; Diazoxide; Epinephrine; Ethanol; Glucosamine; Gl | 1969 |
Effect of streptozotocin on glucose-induced insulin secretion by isolated islets of Langerhans.
Topics: Animals; Antineoplastic Agents; Diabetes Mellitus; Glucose; In Vitro Techniques; Insulin; Insulin An | 1971 |
Effects of streptozotocin on carbohydrate and lipid metabolism in the rat.
Topics: Acetoacetates; Animals; Antibiotics, Antineoplastic; Blood Glucose; Carbamates; Diabetes Mellitus; D | 1971 |
Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.
Topics: Animals; Carbon Radioisotopes; Diabetes Mellitus; In Vitro Techniques; Islets of Langerhans; Liver; | 1973 |
6-Amnionicotinamide (6-AN) as a diabetogenic agent. In vitro and in vivo studies in the rat.
Topics: Animals; Diabetes Mellitus; Disease Models, Animal; Female; Glucose; Insulin; Insulin Secretion; Isl | 1972 |